🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,328 results for “China” Clear

  1. Inhaled Placebo

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ventilator-Associated Pneumonia (VAP)

    small molecule active

    1 trial

  2. Innovative Dietary Formulation (Patent ID: CN110250417A)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    other completed

    1 trial

  3. Intensity-modulated radiotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nasopharyngeal Carcinoma

    other active

    1 trial

  4. Intensive BP treatment group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    small molecule completed

    1 trial

  5. Intestinal Microbiota Transplant (IMT) Capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cardiovascular Disease

    small molecule active

    1 trial

  6. Intranasal Oxytocin (OT) 24 IU

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Participants

    small molecule active

    1 trial

  7. Intravenous dexmedetomidine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Aneurysm Cerebral

    small molecule completed

    1 trial

  8. Intravenous thrombolysis

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Ischemic Stroke

    small molecule active

    1 trial

  9. Intravenous tramadol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Catheter Site Discomfort

    small molecule active

    1 trial

  10. Iron Isomaltoside injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obesity

    small molecule active

    1 trial

  11. Isoniazid

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Kidney Transplant Infection

    small molecule active

    1 trial

  12. Isosorbide Dinitrate 5 MG

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Post-ERCP Acute Pancreatitis

    small molecule active

    1 trial

  13. Itraconazole

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sporotrichosis

    small molecule active

    1 trial

  14. Ivosidenib,Venetoclax,gilteritinib,Selinexor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AML

    small molecule active

    1 trial

  15. JAK Inhibitor

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Antisynthetase Syndrome

    small molecule active

    1 trial

  16. JY231 Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    B-cell Malignancies

    small molecule active

    1 trial

  17. Jianpixiaozhong particles and Wuse Dietotherapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Idiopathic Membranous Nephropathy

    small molecule active

    1 trial

  18. KL003 Cell Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Sickle Cell Disease

    gene therapy active

    1 trial

  19. KL003 cell injection Drug Product

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Transfusion-dependent Beta-Thalassemia

    gene therapy active

    1 trial

  20. Kefir peptide

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Obesity

    other active

    1 trial

  21. LCAR- F33S cells intravenous infusion

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed/Refractory Multiple Myeloma(MM)

    mab active

    1 trial

  22. LCI+white light

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Early Gastric Cancer

    other active

    1 trial

  23. Lang Qingata

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NASH

    small molecule active

    1 trial

  24. Learning with 3D-MR visualization models

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Teaching Innovation

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources